Work

Bortezomib-Based Versus Standard of Care Reduced Intensity Conditioning Hematopoietic Stem Cell Transplantation: A Phase II Randomized Controlled Trial

Year: 2016

Type: article

Study designs: Randomized Controlled Trial, Clinical Trial

Source: Blood

DOI: 10.1182/blood.v128.22.508.508

Authors: John Koreth, Haesook T. Kim, Paulina B Lange, Philippe Armand, Corey S. Cutler, Vincent T. Ho, Brett Glotzbecker, Rushdia Z. Yusuf, Sarah Nikiforow, Bimalangshu R. Dey, Malgorzata McMasters, Jerome Ritz, Bruce R. Blazar, Robert J. Soiffer, Joseph H Antin, Edwin P. Alyea

Institutions: Dana-Farber Cancer Institute, Harvard University, Massachusetts General Hospital, Beth Israel Deaconess Medical Center, University of Minnesota

Language: English

Topic: Hematopoietic Stem Cell Transplantation

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2979797496

FWCI:

Cites:

Cited by:

Related to: 10